New program aims to boost HIV prevention in pregnant women in zimbabwe
NCT ID NCT06226155
First seen Feb 06, 2026 · Last updated Jun 20, 2026 · Updated 16 times
Summary
This study tests a problem-solving program called TENDAI4PrEP to help pregnant women in Zimbabwe take PrEP, a daily pill that prevents HIV. The program also addresses depression and anxiety, which can make it harder to stick with PrEP. Researchers will enroll 132 pregnant women, their partners, and healthcare providers to see if the program is feasible and acceptable. If it works, it could be tested on a larger scale to reduce HIV infections in this vulnerable group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Zimbabwe
RECRUITINGHarare, Zimbabwe
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
problem-solving behavioral intervention
What this could lead to
If successful, this program could help pregnant women in Zimbabwe better prevent HIV by improving PrEP use and reducing psychological distress.
What could go wrong
This is a small early-stage trial focused on feasibility, not proof of effectiveness. The results may not apply to other settings or populations.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.